BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18585574)

  • 1. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
    Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone attenuates allergic inflammation and induces production of regulatory T lymphocytes.
    Wang W; Zhu Z; Zhu B; Ma Z
    Am J Rhinol Allergy; 2010; 24(6):454-8. PubMed ID: 21144225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma agonist induces regulatory T cells in a murine model of allergic rhinitis.
    Wang W; Zhu Z; Zhu B; Ma Z
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):506-13. PubMed ID: 21493225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma negatively regulates allergic rhinitis in mice.
    Fukui N; Honda K; Ito E; Ishikawa K
    Allergol Int; 2009 Jun; 58(2):247-53. PubMed ID: 19307774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis.
    Kang HJ; Cinn YG; Hwang SJ; Won Chae S; Woo JS; Lee SH; Lee HM
    Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1196-200. PubMed ID: 17116814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
    Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
    Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
    J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis.
    Han JL; Ding RY; Zhao L; Ren Z; Jiang XJ
    J Int Med Res; 2008; 36(4):830-6. PubMed ID: 18652780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
    Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
    Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
    Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
    Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
    Han DM; Zhou B; Wang T; Wang XD; Fan EZ
    Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
    Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of uteroglobin in a murine model of allergic rhinitis.
    Won TB; Quan SH; Rhee CS; Min YG; Lee CH
    Acta Otolaryngol Suppl; 2007 Oct; (558):83-9. PubMed ID: 17882576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
    Sasaki Y; Hayashi T; Hasegawa K
    Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An essential role for dendritic cells in human and experimental allergic rhinitis.
    KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN
    J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.